Abbott Laboratories (ABT)
Unlocking Q4 Potential of Abbott (ABT): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Abbott (ABT) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?
ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology and Consumer Diagnostics.
Abbott Laboratories Q4 2024 Earnings Preview
Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. Abbott continues to execute growth businesses with excellent marketing and distribution, allowing them to scale faster and farther than competitors. On the basis of favorable trends, mitigated risks, and earnings expectations, I maintain my buy rating at a price target of $133.90.
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Abbott (ABT) closed at $113.04, marking a -0.69% move from the previous day.
Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Jared Holz
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Squawk on the Street' to discuss outlooks on the healthcare sector in the new year
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Here is how Abbott (ABT) and Acurx Pharmaceuticals, Inc. (ACXP) have performed compared to their sector so far this year.
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years
Want some solid dividend growth stocks with incredible track records of increasing their payouts? Here's a list of stocks that have been raising their dividend payments consistently for more than 50 consecutive years.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
5 MedTech Stocks That Are Poised to Beat the Market in 2025
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices.
My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks
I review here the stocks of six quality companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. Dividend growth investing is not a get-rich-quick strategy, it requires commitment and a long-term mindset. Making a New Year's resolution is a great way to help maintain that mindset. I discuss two scenarios of hypothetical investors who start their journey in 2025. I detail the significant impact a long-term commitment – even without additional investments – can make.
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
A few different elements can make a stock a no-brainer buy. The company could be the leader in its market, or well diversified across various markets.
